Clin Biochem. 2013 Dec 18. pii: S0009-9120(13)00593-6. doi: 10.1016/j.clinbiochem.2013.12.008. [Epub ahead of print]

Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization.

Wei BR1, Simpson RM2.

Author information

• 1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH Building 37, 37 Convent Drive, Bethesda, MD 20892, USA.
• 2Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH Building 37, 37 Convent Drive, Bethesda, MD 20892, USA. Electronic address: ms43b@nih.gov.

Abstract

Standardization of biorepository best practices will enhance the quality of translational biomedical research utilizing patient-derived biobank specimens. Harmonization of pathology quality assurance procedures for biobank accessions has lagged behind other avenues of biospecimen research and biobank development. Comprehension of the cellular content of biorepository specimens is important for discovery of tissue-specific clinically relevant biomarkers for diagnosis and treatment. While rapidly emerging technologies in molecular analyses and data mining create focus on appropriate measures for minimizing pre-analytic artifact-inducing variables, less attention gets paid to annotating the constituent makeup of biospecimens for more effective specimen selection by biobank clients. Both pre-analytic tissue processing and specimen's composition influence acquisition of relevant macromolecules for downstream assays. Pathologist review of biorepository submissions, particularly tissues as part of quality assurance procedures, helps to ensure that the intended target cells are present and in sufficient quantity in accessioned specimens. This manual procedure can be tedious and subjective. Incorporating digital pathology into biobank quality assurance procedures, using automated pattern recognition morphometric image analysis to quantify tissue feature areas in digital whole slide images of tissue sections, can minimize variability and subjectivity associated with routine pathologic evaluations in biorepositories. Whole-slide images and pathologist-reviewed morphometric analyses can be provided to researchers to guide specimen selection. Harmonization of pathology quality assurance methods that minimize subjectivity and improve reproducibility among collections would facilitate research-relevant specimen selection by investigators and could facilitate information sharing in an integrated network approach to biobanking.